Director, EHSS Management System at Bristol-Myers Squibb

Lawrence Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Bachelor’s degree in life sciences, engineering, or a related field; advanced degrees preferred
Minimum 10+ years of EHSS experience in pharmaceutical, biopharmaceutical, or other high-hazard industries
Proven expertise in EHSS management systems, including ISO14001 and ISO45001
Experience in global document governance and digital document management systems (e.g., Veeva)
Demonstrated ability to lead global training development and deployment across global teams
Strong stakeholder engagement, communication, and change management skills
Preferred: Professional certifications (CIH, CSP); ISO 14001/45001 Lead Auditor credential

Responsibilities

Lead the design, deployment, and sustainment of the EHSS management system across global and site-level operations, ensuring alignment with relevant ISO standards and internal requirements
Own lifecycle management of global EHSS standards and procedures, including oversight of global documentation within the enterprise document management system
Lead and oversee execution of core management system elements such as compliance evaluations, risk management, continuous improvement and best practice sharing
Oversee development and delivery of EHSS training programs, collaborating with SMEs, centralized BMS training teams, and external providers; manage LMS integration and content strategy
Prepare and coordinate annual EHSS management reviews, including data analysis, performance evaluation, and executive-level reporting
Partner with EHSS digital systems teams to support deployment and sustainment of digital tools, including AI-enablement, for compliance and risk management
Maintain and manage regulatory subscriptions and ensure integration of relevant standards into EHSS practices
Be senior subject matter expert and leader on management systems, providing leadership expertise to site teams to ensure understanding and effective implementation of management system requirements

Skills

EHSS Management System

ISO Standards

Risk Framework

Document Management

Training Development

Compliance

Strategic Design

Continuous Improvement

Lifecycle Management

Global Operations

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free